Abstract:Background and aim: Gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS) is an autosomal dominant syndrome characterized by fundic gland polyps (FGP) as well as an increased risk of gastric cancer. The syndrome has been recognized as a clinical entity for less than a decade. A clinical suspicion may be complex and can vary from incidental findings of FGPs at gastroscopy to obstructive symptoms with dyspepsia and vomiting. The diagnosis is established by genetic detection of a pathogenic variant in the promotor 1B region of the APC gene. As of yet there are no established clinical criteria for the diagnosis. To increase knowledge of the condition and to discuss possible genetic testing and surveillance strategies, we performed a systematic review of all reported patients with GAPPS. Methods: This review was organized according to PRISMA guidelines. The search, which was conducted on September 7th, 2023, was applied to MEDLINE and restricted to only humans and papers in the English language. Only the studies on patients/families with GAPPS verified by identification of a pathogenic variant in the APC promoter 1B were included. Results: Twelve publications with a total of 113 patients were identified. In all instances the diagnosis was genetically verified with reports of four different variants within the APC promotor 1B region. Eighty-eight patients (90.1%) had gastric polyps, of these seven patients had low-grade dysplasia and five patients had both low- and high-grade dysplasia. Thirty-seven patients (45.7%) underwent gastrectomy. There were no reports of duodenal polyps (0%). Gastric cancer was found in 31 patients (30.1%) with a median age of 48 years (range 19-75). Twenty-six patients died (23.2%) of which 19 had developed gastric cancer (73.1%). One patient was diagnosed with metastatic colorectal cancer (2.2%) and died at 73 years of age. Nineteen patients had colorectal manifestations with < 20 polyps (41.3%). Conclusion: Patients with a pathogenic variant in the APC promoter 1B region have an increased risk of gastric polyposis and early-onset gastric cancer. However, there is considerable variation in clinical expression and penetrance, which makes decisions on surveillance and the timing of prophylactic gastrectomy challenging.

GASTRIC POLYPOSIS AND RISK OF GASTRIC CANCER IN PATIENTS WITH FAMILIAL ADENOMATOUS POLYPOSIS (FAP)

Gastric adenomas and their management in familial adenomatous polyposis

Clinical outcomes of gastric polyps and neoplasms in patients with familial adenomatous polyposis

Two Cases, Too Little, Too Late: Surveillance for Gastric Cancer in Patients with FAP

Prevalence of Gastroduodenal Polyps in Children With Familial Adenomatous Polyposis

Gastrointestinal manifestations in patients with gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS): a systematic review with analysis of individual patient data

A Clinicopathologic Evaluation of Incidental Fundic Gland Polyps With Dysplasia: Implications for Clinical Management

Familial Adenomatous Polyposis within the Pediatric Hereditary Polyposis Registry

Risk of gastric adenoma and adenocarcinoma in patients with familial adenomatous polyposis in Japan: a nationwide multicenter study

Genetic Causes of Familial Adenomatous Polyposis (FAP), Risk Factors and Clinical Outcomes

Endoscopic indicators in patients with familial adenomatous polyposis undergoing duodenal resections – a nationwide Danish cohort study with long-term follow-up

Cancer Risks in Attenuated and Classical Familial Adenomatous Polyposis: A Nationwide Cohort with Matched, Non-Exposed Individuals

An Unsuspecting Case of Familial Adenomatous Polyposis (FAP)

Updated Perspectives on the Diagnosis and Management of Familial Adenomatous Polyposis

S4981 Bridge the GAPPS: A Case Report of Rare Familial Gastric Cancer

Two families with gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS): case reports and literature review

Diffuse Gastric Polyposis in a Young Patient with a Giant Retroperitoneal Mass: A Case Report.

Progression of duodenal neoplasia to advanced adenoma in patients with familial adenomatous polyposis

Classification of fundic gland polyps for predicting gastric neoplasms in Helicobacter pylori-negative patients with familial adenomatous polyposis

Appropriate Management of Attenuated Familial Adenomatous Polyposis: Report of a Case and Review of the Literature

Genetic characteristics and extracolonic phenotypic manifestations in patients with familiar adenomatous polyposis